Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 21;8(2):e001869. doi: 10.1136/openhrt-2021-001869

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Risk of all-cause mortality according to interleukin 6 (IL-6) levels measured 4 months after ST-elevation myocardial infarction (STEMI). (A) Kaplan-Meier plot of all-cause mortality during long-term follow-up (median 70 months) according to high or low (>/<75th percentile) IL-6 levels measured 4 months after STEMI. (B) Univariable and multivariable HRs for long-term all-cause mortality when having high (>75th percentile) IL-6 levels 4 months after STEMI. Data are presented as HRs with 95% CI and p values obtained by Cox regression. IL-6, CRP, NT-proBNP and final infarct size were measured at 4-month follow-up. ^aCRP, C reactive protein; ^bNT-proBNP, N-terminal pro-B-type natriuretic peptide.